What is BatchLine?
BatchLine specializes in providing BatchLine Lite MES, a digital manufacturing execution system designed for the pharmaceutical and other GxP regulated industries. Their innovative solution simplifies and streamlines critical production, quality, and compliance processes. By significantly reducing batch review times and implementation efforts, BatchLine empowers companies in pharmaceuticals, medical devices, biotechnology, and cannabis sectors to digitize operations and enhance adherence to stringent regulatory standards. The platform's modern user experience and robust integration capabilities foster a more efficient and error-proof manufacturing environment.
How much funding has BatchLine raised?
BatchLine has raised a total of $639K across 1 funding round:
Private Equity
$639K
Private Equity (2026): $639K with participation from B-EN-G
Key Investors in BatchLine
B-EN-G
B-EN-G Thai, a subsidiary of Toyo Business Engineering Corporation, is a business engineering firm focused on Production and Cost Management solutions, including their "MCFrame" and "A.S.I.A." ERP systems. They offer comprehensive IT consulting and system implementation services.
What's next for BatchLine?
The recent major strategic investment positions BatchLine for accelerated growth and market expansion. This capital infusion is expected to fuel further development of their digital manufacturing solutions, enhance integration capabilities with existing enterprise systems, and broaden their reach within the pharmaceutical and life sciences sectors. The company's focus on compliance and efficiency in regulated industries suggests a strategic direction towards solidifying its market leadership and potentially exploring new verticals that demand rigorous operational control and digital transformation.
See full BatchLine company page
